Weiping Xie Selected Research

Semaxinib (SU5416)

1/2021	Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells.
1/2020	Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiping Xie Research Topics

Disease

13	Hypoxia (Hypoxemia) 01/2021 - 09/2004
11	Pulmonary Arterial Hypertension 01/2024 - 01/2015
11	Neoplasms (Cancer) 01/2024 - 01/2014
10	Inflammation (Inflammations) 01/2024 - 09/2015
9	Vascular Remodeling 01/2022 - 09/2004
9	Pulmonary Hypertension 07/2019 - 03/2005
8	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2014
5	Fibrosis (Cirrhosis) 03/2024 - 01/2018
5	Adenocarcinoma of Lung 01/2024 - 09/2015
4	Hypertrophy 01/2022 - 06/2012
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 04/2012
4	Right Ventricular Hypertrophy 01/2020 - 09/2004
3	Silicosis 03/2024 - 01/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2014
3	Tuberculosis (Tuberculoses) 05/2022 - 06/2013
2	Pneumonia (Pneumonitis) 03/2024 - 01/2023
2	Hypersensitivity (Allergy) 01/2019 - 06/2017
2	Acute Lung Injury 01/2019 - 01/2019
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 09/2015 - 06/2015
1	Neoplasm Metastasis (Metastasis) 01/2024
1	Venous Thromboembolism 06/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Hyperplasia 01/2023
1	Foreign Bodies (Foreign Body) 01/2022
1	Infections 01/2021

Drug/Important Bio-Agent (IBA)

9	MonocrotalineIBA 01/2022 - 01/2015
8	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2013
6	N- (1- methylethyl)- 1,1,2- trimethylpropylamineIBA 07/2019 - 09/2004
5	InflammasomesIBA 03/2024 - 09/2015
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2015
5	KATP ChannelsIBA 07/2019 - 09/2004
3	Silicon Dioxide (Silica)FDA LinkGeneric 03/2024 - 01/2018
3	NLR ProteinsIBA 03/2024 - 04/2016
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2024 - 10/2018
3	CollagenIBA 01/2022 - 11/2012
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019 - 01/2018
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 01/2018
3	Adenosine Triphosphate (ATP)IBA 01/2019 - 03/2005
3	Nicorandil (SG 75)IBA 01/2019 - 03/2013
3	PotassiumIBA 01/2019 - 03/2005
2	Protein Tyrosine PhosphatasesIBA 01/2024 - 08/2018
2	RNA (Ribonucleic Acid)IBA 05/2022 - 01/2022
2	Interleukin-2 (IL2)IBA 04/2022 - 06/2015
2	peoniflorinIBA 01/2022 - 01/2020
2	SmokeIBA 01/2021 - 06/2012
2	Semaxinib (SU5416)IBA 01/2021 - 01/2020
2	Etanercept (Enbrel)FDA Link 01/2021 - 06/2012
2	Therapeutic UsesIBA 01/2021 - 07/2019
2	fasudil (AT 877)IBA 01/2021 - 01/2019
2	SaltsIBA 01/2021 - 01/2019
2	CytokinesIBA 08/2020 - 09/2015
2	InterleukinsIBA 08/2020 - 09/2015
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2019 - 03/2013
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 10/2018
2	Liraglutide FDA Link 01/2019 - 01/2019
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2019 - 01/2019
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 01/2018
2	Becaplermin (PDGF-BB)FDA Link 01/2019 - 12/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 06/2017
2	Nanoparticle Drug Delivery SystemIBA 01/2019 - 08/2016
2	Caspase 3 (Caspase-3)IBA 12/2016 - 07/2013
2	tetrandrineIBA 08/2016 - 01/2014
2	N-vinyl-2-pyrrolidinoneIBA 08/2016 - 01/2014
2	caprolactoneIBA 08/2016 - 01/2014
2	Interleukin-18 (Interleukin 18)IBA 09/2015 - 09/2015
2	Oxygen (Dioxygen)IBA 04/2015 - 09/2004
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2024
1	EndotoxinsIBA 01/2024
1	IntegrinsIBA 01/2024
1	Class 3 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2024
1	Long Noncoding RNAIBA 01/2023
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2023
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023
1	eupafolinIBA 01/2023
1	Ethambutol (Myambutol)FDA LinkGeneric 04/2022
1	Isoniazid (Ftivazide)FDA LinkGeneric 04/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2022
1	Pyrazinamide FDA LinkGeneric 04/2022
1	PlasticsIBA 01/2022
1	zanubrutinibIBA 01/2022
1	Monoterpenes (Monoterpenoids)IBA 01/2022
1	MetalsIBA 01/2022
1	GlycosidesIBA 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	GraphiteIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2021
1	LactamsIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Tigecycline (Tygacil)FDA Link 01/2021
1	rho-Associated KinasesIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021

Therapy/Procedure

5	Therapeutics 06/2023 - 03/2015
3	Drug Therapy (Chemotherapy) 05/2017 - 06/2015
1	Radiotherapy 06/2023
1	Immunomodulation 01/2022
1	Immunotherapy 01/2022
1	Subcutaneous Injections 01/2021